Repositorio de Universidad Autónoma de Chile.
metadata only
Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis
Background: Migraine is a common and disabling primary headache disorder. Several drugs targeting calcitonin gene-related peptide (CGRP), such as erenumab (an anti-CGRP receptor mAb), have been developed recently. However, the real-world effects of erenumab are not well understood. Objective: To ass
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications#1086924
- MicroRNA Profile and Erenumab Treatment#881092
- The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.#871860
- Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets#909777
- HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs#874823
Record · ID 947972
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive